NLS Pharmaceutics (NLSPW) Short Interest Ratio & Short Volume

Short interest is the volume of NLS Pharmaceutics shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 10,200 shares of NLSPW short. Learn More on NLS Pharmaceutics' current short interest.

NLS Pharmaceutics saw a decrease in short interest in June. As of June 15th, there was short interest totaling 10,200 shares, a decrease of 10.5% from the previous total of 11,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to NLS Pharmaceutics: Ampio Pharmaceuticals, Inc. (0.01%), Calithera Biosciences, Inc. (0.43%), Cocrystal Pharma, Inc. (0.07%), CytoMed Therapeutics Limited (1.20%), Eloxx Pharmaceuticals, Inc. (0.08%), Galapagos NV (2.99%), Indivior PLC (2.85%), MEI Pharma, Inc. (0.02%), NexImmune, Inc. (0.31%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks.

Short selling NLSPW is an investing strategy that aims to generate trading profit from NLS Pharmaceutics as its price is falling. NLSPW shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for NLS Pharmaceutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NLSPW, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NLSPW, twice per month. The most recent reporting period available is June, 15 2025.